REGULATION OF HUMAN TA4 RECEPTOR

Details for Australian Patent Application No. 2002320823 (hide)

Owner BAYER AKTIENGESELLSCHAFT

Inventors ZHU, Zhimin

Pub. Number AU-A-2002320823

PCT Number PCT/EP02/06204

PCT Pub. Number WO2002/101043

Priority 60/296,447 08.06.01 US; 60/331,393 15.11.01 US; 60/372,811 17.04.02 US

Filing date 6 June 2002

Wipo publication date 23 December 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 031/70 - Carbohydrates

A61K 038/17 Medicinal preparations containing peptides - from animals

C07K 014/705 Peptides having more than 20 amino acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/296,447 08.06.01 US; 60/331,393 15.11.01 US; 60/372,811 17.04.02 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002320823

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320824-REGULATION OF HUMAN TA5 RECEPTOR

2002320822-Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carba moylbenzofuran-5-yl)piperazine hydrochloride